New Vandetanib analogs: fused tricyclic quinazolines with antiangiogenic potential

ISSN： 0167-6997

Source： Investigational New Drugs, Vol.30, Iss.2, 2012-04, pp. : 594-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepoxilin Analogs, Potential New Therapeutics in Disease

Current Pharmaceutical Design, Vol. 12, Iss. 8, 2006-03 ,pp. : 963-969

Bentham Science Publishers

Access to resources Recommend Favorite

Design, Synthesis and Computational Studies of New Benzothiazole Substituted Quinazolines as Potential Antimicrobial Agents

Letters in Drug Design & Discovery, Vol. 10, Iss. 10, 2013-12 ,pp. : 957-966

Bentham Science Publishers

Access to resources Recommend Favorite

Antiangiogenic Agents: Studies on Fumagillin and Curcumin Analogs

Current Pharmaceutical Design, Vol. 11, Iss. 3, 2005-02 ,pp. : 357-373

Bentham Science Publishers

Access to resources Recommend Favorite

Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties

Current Pharmaceutical Design, Vol. 19, Iss. 11, 2013-04 ,pp. : 2047-2069

Bentham Science Publishers

Access to resources Recommend Favorite

Potential anti-angiogenic sulfates of andrographolide

By Xiao Xiao-Wu Fu Hui-Zheng Luo Yue-Hua Wei Xiao-Yi

Journal of Asian Natural Products Research, Vol. 15, Iss. 8, 2013-08 ,pp. : 809-818

Taylor & Francis Ltd

Access to resources Recommend Favorite